Cosopt — Cigna
reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers
Preferred products
- generic brimonidine 0.2%/timolol maleate 0.5% ophthalmic solution
- generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution
- generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution (generic Cosopt PF)
Initial criteria
- Patient has tried one Step 1 Product (generic brimonidine 0.2%/timolol maleate 0.5% ophthalmic solution [generic Combigan], generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution [generic Cosopt], or generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution [generic Cosopt PF])
Approval duration
1 year